Table of Content

1 Iopamidol Injection Market Overview
1.1 Product Overview and Scope of Iopamidol Injection
1.2 Iopamidol Injection Segment by Type
1.2.1 Global Iopamidol Injection Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 9 g I/ 30 mL
1.2.3 11.1 g I/ 30 mL
1.2.4 Others
1.3 Iopamidol Injection Segment by Application
1.3.1 Global Iopamidol Injection Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Iopamidol Injection Market Size Estimates and Forecasts
1.4.1 Global Iopamidol Injection Revenue 2016-2027
1.4.2 Global Iopamidol Injection Sales 2016-2027
1.4.3 Iopamidol Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Iopamidol Injection Market Competition by Manufacturers
2.1 Global Iopamidol Injection Sales Market Share by Manufacturers (2016-2021)
2.2 Global Iopamidol Injection Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Iopamidol Injection Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Iopamidol Injection Manufacturing Sites, Area Served, Product Type
2.5 Iopamidol Injection Market Competitive Situation and Trends
2.5.1 Iopamidol Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Iopamidol Injection Players Market Share by Revenue
2.5.3 Global Iopamidol Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Iopamidol Injection Retrospective Market Scenario by Region
3.1 Global Iopamidol Injection Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Iopamidol Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Iopamidol Injection Market Facts & Figures by Country
3.3.1 North America Iopamidol Injection Sales by Country
3.3.2 North America Iopamidol Injection Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Iopamidol Injection Market Facts & Figures by Country
3.4.1 Europe Iopamidol Injection Sales by Country
3.4.2 Europe Iopamidol Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Iopamidol Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Iopamidol Injection Sales by Region
3.5.2 Asia Pacific Iopamidol Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Iopamidol Injection Market Facts & Figures by Country
3.6.1 Latin America Iopamidol Injection Sales by Country
3.6.2 Latin America Iopamidol Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Iopamidol Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Iopamidol Injection Sales by Country
3.7.2 Middle East and Africa Iopamidol Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Iopamidol Injection Historic Market Analysis by Type
4.1 Global Iopamidol Injection Sales Market Share by Type (2016-2021)
4.2 Global Iopamidol Injection Revenue Market Share by Type (2016-2021)
4.3 Global Iopamidol Injection Price by Type (2016-2021)

5 Global Iopamidol Injection Historic Market Analysis by Application
5.1 Global Iopamidol Injection Sales Market Share by Application (2016-2021)
5.2 Global Iopamidol Injection Revenue Market Share by Application (2016-2021)
5.3 Global Iopamidol Injection Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporation Information
6.1.2 Bracco Imaging Description and Business Overview
6.1.3 Bracco Imaging Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bracco Imaging Iopamidol Injection Product Portfolio
6.1.5 Bracco Imaging Recent Developments/Updates
6.2 Sanochemia
6.2.1 Sanochemia Corporation Information
6.2.2 Sanochemia Description and Business Overview
6.2.3 Sanochemia Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanochemia Iopamidol Injection Product Portfolio
6.2.5 Sanochemia Recent Developments/Updates
6.3 Consentis
6.3.1 Consentis Corporation Information
6.3.2 Consentis Description and Business Overview
6.3.3 Consentis Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Consentis Iopamidol Injection Product Portfolio
6.3.5 Consentis Recent Developments/Updates
6.4 T2Pharma
6.4.1 T2Pharma Corporation Information
6.4.2 T2Pharma Description and Business Overview
6.4.3 T2Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 T2Pharma Iopamidol Injection Product Portfolio
6.4.5 T2Pharma Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bayer Iopamidol Injection Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Takeda
6.6.1 Takeda Corporation Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Takeda Iopamidol Injection Product Portfolio
6.6.5 Takeda Recent Developments/Updates
6.7 Fuji Pharma
6.6.1 Fuji Pharma Corporation Information
6.6.2 Fuji Pharma Description and Business Overview
6.6.3 Fuji Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Fuji Pharma Iopamidol Injection Product Portfolio
6.7.5 Fuji Pharma Recent Developments/Updates
6.8 Hikari Pharmaceutical
6.8.1 Hikari Pharmaceutical Corporation Information
6.8.2 Hikari Pharmaceutical Description and Business Overview
6.8.3 Hikari Pharmaceutical Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Hikari Pharmaceutical Iopamidol Injection Product Portfolio
6.8.5 Hikari Pharmaceutical Recent Developments/Updates
6.9 BeiLu Pharma
6.9.1 BeiLu Pharma Corporation Information
6.9.2 BeiLu Pharma Description and Business Overview
6.9.3 BeiLu Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
6.9.4 BeiLu Pharma Iopamidol Injection Product Portfolio
6.9.5 BeiLu Pharma Recent Developments/Updates

7 Iopamidol Injection Manufacturing Cost Analysis
7.1 Iopamidol Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Iopamidol Injection
7.4 Iopamidol Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Iopamidol Injection Distributors List
8.3 Iopamidol Injection Customers

9 Iopamidol Injection Market Dynamics
9.1 Iopamidol Injection Industry Trends
9.2 Iopamidol Injection Growth Drivers
9.3 Iopamidol Injection Market Challenges
9.4 Iopamidol Injection Market Restraints

10 Global Market Forecast
10.1 Iopamidol Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Iopamidol Injection by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Iopamidol Injection by Type (2022-2027)
10.2 Iopamidol Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Iopamidol Injection by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Iopamidol Injection by Application (2022-2027)
10.3 Iopamidol Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Iopamidol Injection by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Iopamidol Injection by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Iopamidol Injection Sales (K L) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Iopamidol Injection Sales (K L) Comparison by Application (2021-2027)
Table 3. Global Iopamidol Injection Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Iopamidol Injection Covered in This Study
Table 5. Global Iopamidol Injection Sales (K L) of Key Manufacturers (2016-2021)
Table 6. Global Iopamidol Injection Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Iopamidol Injection Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Iopamidol Injection Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Iopamidol Injection Average Price (US$/L) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Iopamidol Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Iopamidol Injection Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Iopamidol Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iopamidol Injection as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Iopamidol Injection Sales by Region (2016-2021) & (K L)
Table 16. Global Iopamidol Injection Sales Market Share by Region (2016-2021)
Table 17. Global Iopamidol Injection Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Iopamidol Injection Sales by Country (2016-2021) & (K L)
Table 19. North America Iopamidol Injection Sales Market Share by Country (2016-2021)
Table 20. North America Iopamidol Injection Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Iopamidol Injection Revenue Market Share by Country (2016-2021)
Table 22. Europe Iopamidol Injection Sales by Country (2016-2021) & (K L)
Table 23. Europe Iopamidol Injection Sales Market Share by Country (2016-2021)
Table 24. Europe Iopamidol Injection Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Iopamidol Injection Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Iopamidol Injection Sales by Region (2016-2021) & (K L)
Table 27. Asia Pacific Iopamidol Injection Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Iopamidol Injection Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Iopamidol Injection Revenue Market Share by Region (2016-2021)
Table 30. Latin America Iopamidol Injection Sales by Country (2016-2021) & (K L)
Table 31. Latin America Iopamidol Injection Sales Market Share by Country (2016-2021)
Table 32. Latin America Iopamidol Injection Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Iopamidol Injection Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Iopamidol Injection Sales by Country (2016-2021) & (K L)
Table 35. Middle East and Africa Iopamidol Injection Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Iopamidol Injection Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Iopamidol Injection Revenue Market Share by Country (2016-2021)
Table 38. Global Iopamidol Injection Sales (K L) by Type (2016-2021)
Table 39. Global Iopamidol Injection Sales Market Share by Type (2016-2021)
Table 40. Global Iopamidol Injection Revenue (Million US$) by Type (2016-2021)
Table 41. Global Iopamidol Injection Revenue Share by Type (2016-2021)
Table 42. Global Iopamidol Injection Price (US$/L) by Type (2016-2021)
Table 43. Global Iopamidol Injection Sales (K L) by Application (2016-2021)
Table 44. Global Iopamidol Injection Sales Market Share by Application (2016-2021)
Table 45. Global Iopamidol Injection Revenue (Million US$) by Application (2016-2021)
Table 46. Global Iopamidol Injection Revenue Share by Application (2016-2021)
Table 47. Global Iopamidol Injection Price (US$/L) by Application (2016-2021)
Table 48. Bracco Imaging Corporation Information
Table 49. Bracco Imaging Description and Business Overview
Table 50. Bracco Imaging Iopamidol Injection Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 51. Bracco Imaging Iopamidol Injection Product
Table 52. Bracco Imaging Recent Developments/Updates
Table 53. Sanochemia Corporation Information
Table 54. Sanochemia Description and Business Overview
Table 55. Sanochemia Iopamidol Injection Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 56. Sanochemia Iopamidol Injection Product
Table 57. Sanochemia Recent Developments/Updates
Table 58. Consentis Corporation Information
Table 59. Consentis Description and Business Overview
Table 60. Consentis Iopamidol Injection Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 61. Consentis Iopamidol Injection Product
Table 62. Consentis Recent Developments/Updates
Table 63. T2Pharma Corporation Information
Table 64. T2Pharma Description and Business Overview
Table 65. T2Pharma Iopamidol Injection Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 66. T2Pharma Iopamidol Injection Product
Table 67. T2Pharma Recent Developments/Updates
Table 68. Bayer Corporation Information
Table 69. Bayer Description and Business Overview
Table 70. Bayer Iopamidol Injection Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 71. Bayer Iopamidol Injection Product
Table 72. Bayer Recent Developments/Updates
Table 73. Takeda Corporation Information
Table 74. Takeda Description and Business Overview
Table 75. Takeda Iopamidol Injection Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 76. Takeda Iopamidol Injection Product
Table 77. Takeda Recent Developments/Updates
Table 78. Fuji Pharma Corporation Information
Table 79. Fuji Pharma Description and Business Overview
Table 80. Fuji Pharma Iopamidol Injection Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 81. Fuji Pharma Iopamidol Injection Product
Table 82. Fuji Pharma Recent Developments/Updates
Table 83. Hikari Pharmaceutical Corporation Information
Table 84. Hikari Pharmaceutical Description and Business Overview
Table 85. Hikari Pharmaceutical Iopamidol Injection Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 86. Hikari Pharmaceutical Iopamidol Injection Product
Table 87. Hikari Pharmaceutical Recent Developments/Updates
Table 88. BeiLu Pharma Corporation Information
Table 89. BeiLu Pharma Description and Business Overview
Table 90. BeiLu Pharma Iopamidol Injection Sales (K L), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 91. BeiLu Pharma Iopamidol Injection Product
Table 92. BeiLu Pharma Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Iopamidol Injection Distributors List
Table 96. Iopamidol Injection Customers List
Table 97. Iopamidol Injection Market Trends
Table 98. Iopamidol Injection Growth Drivers
Table 99. Iopamidol Injection Market Challenges
Table 100. Iopamidol Injection Market Restraints
Table 101. Global Iopamidol Injection Sales Forecast by Type (2022-2027) & (K L)
Table 102. Global Iopamidol Injection Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Iopamidol Injection Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Iopamidol Injection Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Iopamidol Injection Sales Forecast by Application (2022-2027) & (K L)
Table 106. Global Iopamidol Injection Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Iopamidol Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Iopamidol Injection Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Iopamidol Injection Sales Forecast by Region (2022-2027) & (K L)
Table 110. Global Iopamidol Injection Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Iopamidol Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Iopamidol Injection Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Iopamidol Injection
Figure 2. Global Iopamidol Injection Market Share by Type in 2020 & 2027
Figure 3. 9 g I/ 30 mL Product Picture
Figure 4. 11.1 g I/ 30 mL Product Picture
Figure 5. Others Product Picture
Figure 6. Global Iopamidol Injection Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Global Iopamidol Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Iopamidol Injection Market Size 2016-2027 (US$ Million)
Figure 11. Global Iopamidol Injection Sales 2016-2027 (K L)
Figure 12. Global Iopamidol Injection Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Iopamidol Injection Sales Share by Manufacturers in 2020
Figure 14. Global Iopamidol Injection Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Iopamidol Injection Players: Market Share by Revenue in 2020
Figure 16. Iopamidol Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Iopamidol Injection Sales Market Share by Region (2016-2021)
Figure 18. Global Iopamidol Injection Sales Market Share by Region in 2020
Figure 19. Global Iopamidol Injection Revenue Market Share by Region (2016-2021)
Figure 20. Global Iopamidol Injection Revenue Market Share by Region in 2020
Figure 21. United States Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Colombia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Iopamidol Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Iopamidol Injection by Type (2016-2021)
Figure 45. Sales Market Share of Iopamidol Injection by Application (2016-2021)
Figure 46. Sales Market Share of Iopamidol Injection by Application in 2020
Figure 47. Revenue Share of Iopamidol Injection by Application (2016-2021)
Figure 48. Revenue Share of Iopamidol Injection by Application in 2020
Figure 49. Manufacturing Cost Structure of Iopamidol Injection
Figure 50. Manufacturing Process Analysis of Iopamidol Injection
Figure 51. Iopamidol Injection Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed